FAKTOR-OPTIONSSCHEIN - MEDIFAST Stock

Certificat

DE000MB8CC87

Market Closed - Börse Stuttgart 10:57:26 2024-06-11 EDT
94.98 EUR -1.55% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDIFAST
Current month+50.19%
1 month+39.42%
Date Price Change
24-06-11 94.98 -1.55%
24-06-10 96.48 +11.74%
24-06-07 86.34 +0.19%
24-06-06 86.18 +16.10%
24-06-05 74.23 +6.24%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 10:57 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDIFAST, INC.
Issuer Morgan Stanley
WKN MB8CC8
ISINDE000MB8CC87
Date issued 2023-07-05
Strike 31.58 $
Maturity Unlimited
Parity 0.1 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 96.48
Lowest since issue 7.28

Company Profile

Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Sector
-
More about the company

Ratings for Medifast, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Consensus: Medifast, Inc.

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
21.05 USD
Average target price
21.25 USD
Spread / Average Target
+0.95%
Consensus